Barabe Joins Affymetrix as Executive Vice President and Chief Financial Officer SANTA CLARA, Calif.--(BUSINESS WIRE)--Mar 15, 2010 - Affymetrix, Inc. (NASDAQ:AFFX) today announced that Timothy Barabe ...

Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $80 million for the third quarter of 2012, with revenue of ...

The stock market closed another successful week on Friday, and major market benchmarks climbed toward their highest levels of the year. Many market commentators focused on the impact of the Federal ...

Xcel microarray is built around Affymetrix’ Human Genome U133 Plus 2.0 array. Affymetrix negotiated exclusive distribution rights to Almac Group’s Xcel™ array microarray, which has been developed for ...

(Reuters) - Gene sequencing products maker Affymetrix Inc delayed a shareholder voting on its deal to be acquired by Thermo Fisher Scientific Inc , saying a raised offer from its former executives ...

OXFORD, England--(BUSINESS WIRE)--Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational ...

BANGALORE (Reuters) - Affymetrix Inc , which makes arrays to analyze genetic data, forecast third-quarter revenue below analysts' estimates, citing increased competition for academic research funding ...

Affymetrix adds complementary products in genetic analysis that are used in cytogenetics, genotyping and gene expression. The company’s innovative microarray platform will strengthen Thermo Fisher’s ...

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...

Microarray giant Affymetrix http://www.affymetrix.com of Santa Clara, Calif., is raising the bar for whole-genome association studies. The first in a planned line of ...

The acquisition of Affymetrix, a leading provider of cellular and genetic analysis products, will strengthen Thermo's ...

Starwood Bidding War Escalates | ValueAct Pays a Price for Supporting Valeant By Amie Tsang After examining a new offer from Origin Technologies, Affymetrix concluded that Thermo Fisher’s bid, while ...